Compare Supplements

Investigational — NO approved monotherapy dose. Phase-2 trials used once-weekly subcutaneous injection with stepwise escalation up to 4.5 mg maintenance. There is no approved standalone regimen; do not self-dose an unapproved drug.

Any time

Once-weekly subcutaneous injection (investigational only)

30grams

Any time · with food (preferred)

Whey Protein Isolate

• Not a dietary supplement and not an approved standalone drug — investigational; do not self-source grey-market vials
• History of pancreatitis (amylin/incretin-class caution)
• Pregnancy and breastfeeding

• Oral medications (delayed gastric emptying)
• Insulin / insulin secretagogues (sulfonylureas)
• GLP-1 / incretin drugs (e.g. semaglutide)

• Milk allergy (use plant-based alternatives)
• Severe lactose intolerance (use isolate or lactose-free)

• Levodopa
• Levothyroxine
• Alendronate (bisphosphonates)